CPT 00534: Anesthesia for Transvenous Cardioverter–Defibrillator Insertion
Commercial payers pay $83 on average nationally for this procedure.
CPT code 00534 describes anesthesia services provided when a patient undergoes transvenous cardioverter–defibrillator insertion, where a surgeon or proceduralist inserts a device via a cervical vein into the heart chambers to treat arrhythmia; service type: anesthesia for cardiac device implantation; typical site of service: operating room or cardiac catheterization lab.
For related coverage guidance, see recent payer policy updates: Intravenous Anesthetics for the Treatment of Chronic Pain and Psychiatric or Substance Use Disorders, Intravenous Anesthetics for the Treatment of Chronic Pain and Psychiatric or Substance Use Disorders, Intravenous Anesthetics for the Treatment of Chronic Pain and Psychiatric or Substance Use Disorders.
Customize your policy alerts
Sign up for cpt 00534 policy alerts
Get alerted when payer policies referencing 00534 are released or updated.
Monitor payer policy activity
National Reimbursement Benchmarks
National commercial reimbursement for CPT 00534 centers near the BUCA average commercial rate of $82.90, with individual payers spreading above and below that midpoint. Blue Cross Blue Shield's interquartile spread (P75–P25) is $39.40, UnitedHealth Group is $27.80, Cigna is $54.20, Aetna is $112.50, and BUCA's IQR is $50.60. Aetna shows the widest dispersion by a large margin, indicating substantial variability in higher-end contractual rates, while UnitedHealth Group displays the tightest interquartile band, suggesting more consistent contracted commercial payments.
Comparing median and mean behavior, Cigna and BUCA sit relatively close to the commercial-average level, whereas Aetna’s mean ($127.80) and higher P90 reflect a heavier right tail. Blue Cross Blue Shield and UnitedHealth Group have lower means and medians, with UnitedHealth Group’s narrow IQR highlighting constrained mid‑range pricing. These contrasts illustrate how payer-specific contracting dynamics create meaningful differences around the BUCA commercial benchmark of $82.90.